0001628280-24-024342.txt : 20240520 0001628280-24-024342.hdr.sgml : 20240520 20240520161034 ACCESSION NUMBER: 0001628280-24-024342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240516 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Autor Deborah M. CENTRAL INDEX KEY: 0001884671 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 24964538 MAIL ADDRESS: STREET 1: C/O PARDES BIOSCIENCES, INC. STREET 2: 2173 SALK AVE., SUITE 250, PMB#052 CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 wk-form4_1716235819.xml FORM 4 X0508 4 2024-05-16 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001884671 Autor Deborah M. C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 1 0 0 0 0 Class A Common Stock 2024-05-16 4 S 0 14553 6.76 D 116849 D Class A Common Stock 2024-05-17 4 S 0 23447 6.727 D 93402 D The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.79 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.70 to $6.77 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Denis Butkovic, Attorney-in-Fact 2024-05-20